Number of items: 8.
Article
Similarities and differences in Health Technology Assessment systems and implications for coverage decisions:evidence from 32 countries. (2022)
Fontrier, Anna-Maria and Visintin, Erica and Kanavos, Panos
picture_as_pdf
Use of the ESMO-magnitude of clinical benefit scale to guide HTA recommendations on coverage and reimbursement for cancer medicines:a retrospective analysis.
Kanavos, Panos and Visintin, Erica and Angelis, Aris
picture_as_pdf
Using IMPrESS to guide policy change in multiple sclerosis.
Tinelli, Michela and Kanavos, Panos and Efthymiadou, Olina and Visintin, Erica and Grimaccia, Federico and Mossman, Jean
Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis:HTA evidence from seven OECD countries.
Visintin, Erica and Tinelli, Michela and Kanavos, Panos
Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study.
Nicod, Elena and Maynou, Laia and Visintin, Erica and Cairns, John
Conference or Workshop Item
Social impact of MS – the family burden.
Kanavos, Panos and Tinelli, Michela and Efthymiadou, Olina and Visintin, Erica and Grimaccia, Federico and Mossman, Jean
Towards better outcomes in multiple sclerosis by addressing policy change: the International MultiPlE Sclerosis Study (IMPrESS).
Kanavos, Panos and Tinelli, Michela and Efthymiadou, Olina and Visintin, Erica and Grimaccia, Federico and Mossman, Jean
